Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer screening. Why the controversy?

P J Walther1

  • 1Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.

Surgical Oncology Clinics of North America
|April 1, 1995
PubMed
Summary

New technologies drive prostate cancer screening, but clinical use remains controversial. Clinicians need to understand disease natural history and screening methods before widespread adoption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.

Cancer research·2001
Same author

Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.

Urology·2001
Same author

Contemporary chemotherapeutic approaches for the treatment of hormone-refractory prostate carcinoma.

World journal of urology·2000
Same author

Time for a neoadjuvant chemotherapy strategy in prostate cancer?

Current opinion in urology·2000
Same author

Early onset baldness and prostate cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2000
Same author

Interstitial brachytherapy for prostate cancer--just an expensive variant of 'watchful waiting'?

Current opinion in urology·2000

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Technological advancements have increased prostate cancer screening.
  • The clinical utility of early prostate cancer detection is debated.
  • Controversy exists regarding the benefits and risks of widespread screening.

Purpose of the Study:

  • To highlight the ongoing debate surrounding prostate cancer screening.
  • To emphasize the need for a thorough understanding of screening methodologies.
  • To underscore the importance of natural history and risk factors in prostate cancer detection.

Main Methods:

  • Review of current prostate cancer screening technologies.
  • Analysis of the natural history of prostate cancer.
  • Examination of epidemiologic factors influencing prostate cancer risk.

Main Results:

  • Prostate cancer screening is expanding due to new technologies.
  • Clinical application of screening is controversial and lacks definitive trial data.
  • Understanding disease progression and risk factors is crucial for clinicians.

Conclusions:

  • Randomized clinical trials are needed to establish the definitive value of prostate cancer screening.
  • Clinicians must possess comprehensive knowledge of prostate cancer epidemiology, natural history, and screening tool limitations.
  • Informed decision-making regarding prostate cancer screening requires a balanced perspective on benefits and risks.

Related Experiment Videos